Drug Side Effects
Search
CHONDROSARCOMA METASTATIC
CHONDROSARCOMA METASTATIC
was reported 27 times
CHONDROSARCOMA METASTATIC is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Actinomycin [EPC]
2
0.0009
1
Programmed Death Ligand-1 Blocker [EPC]
2
0.0001
2
CTLA-4-directed Blocking Antibody [EPC]
2
0.0000
3
Topoisomerase Inhibitor [EPC]
3
0.0000
4
Thiazide-like Diuretic [EPC]
1
0.0000
5
Xanthine Oxidase Inhibitor [EPC]
4
0.0000
6
Hepatitis C Virus NS5A Inhibitor [EPC]
1
0.0000
7
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
1
0.0000
8
Alkylating Drug [EPC]
4
0.0000
9
Platinum-based Drug [EPC]
4
0.0000
10
Microtubule Inhibitor [EPC]
2
0.0000
11
Folate Analog Metabolic Inhibitor [EPC]
5
0.0000
12
gamma-Aminobutyric Acid-ergic Agonist [EPC]
1
0.0000
13
CD20-directed Cytolytic Antibody [EPC]
3
0.0000
14
Thalidomide Analog [EPC]
4
0.0000
15
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
16
Kinase Inhibitor [EPC]
3
0.0000
17
Corticosteroid [EPC]
6
0.0000
18
Nonsteroidal Anti-inflammatory Drug [EPC]
6
0.0000
19
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
20
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
21
Loop Diuretic [EPC]
1
0.0000
22
Platelet Aggregation Inhibitor [EPC]
1
0.0000